BUSINESSThe Marijuana Herald
Review finds acidic cannabinoids promising but still short on human clinical evidence
A peer-reviewed review in Neuroscience and Biobehavioral Reviews found that THCA, CBDA, CBGA and related acidic cannabinoids are pharmacologically active and show preclinical potential across several brain disorders. The authors found no randomized controlled trials of purified acidic cannabinoids for those conditions, so Oklahoma product developers should treat the findings as an R&D signal rather than substantiation for therapeutic marketing claims.
Published Oct 3, 2026
Read the full article at The Marijuana Herald#national#research#product-development#compliance
Read the original source
Leafy summaries provide industry context. Confirm details with The Marijuana Herald.